Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpelisib Challenge Test (ACT) for Assessment of Pancreatic β-Cell Reserve, Pilot & Feasibility Study

NCT07778524 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT07778524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07778524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpelisib Challenge Test (ACT) for Assessment of Pancreatic β-Cell Reserve, Pilot & Feasibility Study
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Recruiting
Start date
September 2, 2026
Completion date
August 31, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult participants, insulin resistance, obesity & overweight, type 2 diabetes